IMAX (NYSE:IMAX) Announces Earnings Results

IMAX (NYSE:IMAX) issued its quarterly earnings results on Thursday. The company reported $0.43 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.28 by $0.15, FiscalAI reports. IMAX had a return on equity of 13.61% and a net margin of 9.08%.The company had revenue of $102.84 million for the quarter, compared to the consensus estimate of $94.69 million. During the same quarter in the prior year, the business posted $0.26 earnings per share. IMAX’s revenue for the quarter was up 12.2% on a year-over-year basis.

Here are the key takeaways from IMAX’s conference call:

• IMAX said Q2 results beat consensus across key metrics, with revenue up 12% to $103 million, adjusted EPS up 65% to $0.43, and adjusted EBITDA of $48 million at a 46.6% margin.
• The Odyssey is driving extraordinary early box office performance, including a $52 million global opening, 75% domestic occupancy, and record weekday holds, which management says could make 2026 box office a record year for IMAX.
• Management highlighted a strong content pipeline for the back half of 2026 and into 2027, led by Dune: Part Three, Spider-Man: Brand New Day, and several other Filmed for IMAX and IMAX 70mm titles that could extend momentum.
• Exhibitor demand remains strong, with 38 system installations in Q2 and 36 system signings, while year-to-date signings reached 62, supporting continued global network expansion.
• IMAX is also pushing newer growth initiatives such as merchandising and an in-vehicle entertainment partnership in China, which management views as untapped opportunities but still early-stage.

IMAX Stock Up 10.4%

Shares of NYSE IMAX traded up $4.09 during midday trading on Thursday, hitting $43.39. The stock had a trading volume of 2,472,763 shares, compared to its average volume of 1,131,107. The stock has a 50 day simple moving average of $39.60 and a 200-day simple moving average of $37.94. The company has a market capitalization of $2.39 billion, a PE ratio of 66.57, a P/E/G ratio of 1.39 and a beta of 0.37. IMAX has a 1 year low of $24.20 and a 1 year high of $45.52.

Insider Activity at IMAX

In related news, CEO Richard L. Gelfond sold 8,943 shares of the business’s stock in a transaction that occurred on Monday, April 27th. The stock was sold at an average price of $37.33, for a total transaction of $333,842.19. Following the completion of the sale, the chief executive officer directly owned 765,002 shares in the company, valued at approximately $28,557,524.66. The trade was a 1.16% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders own 20.55% of the company’s stock.

Institutional Investors Weigh In On IMAX

Several institutional investors and hedge funds have recently added to or reduced their stakes in the business. CIBC Private Wealth Group LLC acquired a new stake in shares of IMAX in the third quarter valued at about $27,000. Quarry LP boosted its position in IMAX by 166.8% during the fourth quarter. Quarry LP now owns 875 shares of the company’s stock worth $32,000 after acquiring an additional 547 shares during the last quarter. Caitong International Asset Management Co. Ltd boosted its position in IMAX by 2,310.4% during the third quarter. Caitong International Asset Management Co. Ltd now owns 1,157 shares of the company’s stock worth $38,000 after acquiring an additional 1,109 shares during the last quarter. Aster Capital Management DIFC Ltd grew its stake in IMAX by 863.0% during the 4th quarter. Aster Capital Management DIFC Ltd now owns 1,666 shares of the company’s stock valued at $62,000 after acquiring an additional 1,493 shares in the last quarter. Finally, Kestra Advisory Services LLC purchased a new stake in IMAX during the 4th quarter valued at about $74,000. Institutional investors and hedge funds own 93.51% of the company’s stock.

Analysts Set New Price Targets

Several research analysts have recently weighed in on the company. Benchmark reaffirmed a “buy” rating on shares of IMAX in a research note on Monday, June 22nd. Barrington Research lifted their price target on shares of IMAX from $42.00 to $46.00 and gave the company an “outperform” rating in a research note on Friday, May 1st. Seaport Research Partners reissued a “buy” rating and issued a $50.00 price target on shares of IMAX in a research note on Wednesday, June 24th. Roth Capital reissued a “buy” rating and issued a $48.00 price target on shares of IMAX in a report on Thursday. Finally, Keefe, Bruyette & Woods restated a “market perform” rating and set a $60.00 price objective on shares of IMAX in a research report on Friday, May 22nd. Nine research analysts have rated the stock with a Buy rating and three have given a Hold rating to the company’s stock. Based on data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and an average price target of $47.90.

IMAX News Summary

Here are the key news stories impacting IMAX this week:

• Positive Sentiment: IMAX beat second-quarter expectations, reporting EPS of $0.43 versus the $0.28 consensus and revenue of $102.84 million versus $94.69 million expected. The company also posted 12.2% year-over-year revenue growth, reinforcing momentum in its core business. Article Title
• Positive Sentiment: Management highlighted The Odyssey as a potentially “transformational” event for IMAX, with the film’s debut already generating unusually strong IMAX ticket sales and broad media attention around the company’s 70mm and premium-large-format exposure. Article Title
• Positive Sentiment: Heavy call-option activity suggests traders are positioning for more upside, with call volume jumping well above normal levels. That kind of activity often signals bullish sentiment around a stock’s near-term outlook.
• Neutral Sentiment: Several articles focused on the record-breaking opening weekend for The Odyssey, including strong IMAX ticket participation and premium-screen demand. These stories are supportive for the brand, but they are more indirect than the earnings results in terms of immediate stock impact.
• Neutral Sentiment: Rosenblatt Securities reiterated a “Buy” rating, which adds a favorable analyst backdrop, though it is not as market-moving as the quarterly beat.

About IMAX

IMAX Corporation is a global leader in immersive entertainment technologies, specializing in the design, manufacture and distribution of high-resolution cameras, projectors, and proprietary software solutions that enhance both film production and theatrical exhibition. The company licenses its premium large-format system to theatre owners and filmmakers around the world, enabling audiences to experience movies with greater clarity, scale and sound fidelity. IMAX also offers turnkey theatre development services, assisting cinema operators with auditorium design, installation and custom branding to optimize the customer experience.

Founded in 1967 and headquartered in Mississauga, Ontario, IMAX has built a reputation for pioneering film-format innovations, including its patented dual 15-perforation, 70-millimeter projection system.